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Background. Despite the availability of rapid diagnostic tests and inexpensive treatment for pregnant women, maternal-child
syphilis transmission remains a leading cause of perinatal morbidity and mortality in developing countries. In Haiti, more than
3000 babies are born with congenital syphilis annually. Methods and Findings. From 2007 to 2011, we used a sequential time
series, multi-intervention study design in fourteen clinics throughout Haiti to improve syphilis testing and treatment in pregnancy.
The two primary interventions were the introduction of a rapid point-of-care syphilis test and systems strengthening based on
quality improvement (QI) methods. Syphilis testing increased from 91.5% prediagnostic test to 95.9% after (𝑃 < 0.001) and further
increased to 96.8% (𝑃 < 0.001) after the QI intervention. Despite high rates of testing across all time periods, syphilis treatment
lagged behind and only increased from 70.3% to 74.7% after the introduction of rapid tests (𝑃 = 0.27), but it improved significantly
from 70.2% to 84.3% (𝑃 < 0.001) after the systems strengthening QI intervention. Conclusion. Both point-of-care diagnostic
testing and health systems-based quality improvement interventions can improve the delivery of specific evidence-based healthcare
interventions to prevent congenital syphilis at scale in Haiti. Improved treatment rates for syphilis were seen only after the use of
systems-based quality improvement approaches.
1. Introduction
Congenitally acquired syphilis remains a leading cause of
perinatal morbidity and mortality in developing countries
with an estimated 1.5 million annually affected pregnancies
worldwide [1]. In Haiti, studies document that more than
3,000 babies are born with congenital syphilis each year [2].
More than half of these result in still-births or perinatal death
[3, 4].
Syphilis is easily detected during antenatal care using
rapid test technology for point-of-care diagnosis [5, 6]. Same
day treatment can be provided with a single shot of penicillin
preventing more than 90% of congenital transmission [3].
Point-of-care diagnosis and same-day treatment can prevent
high rates of lost to follow up that occur when treatment
is provided at a second visit. Studies in Haiti and Sub-
Saharan Africa demonstrate that when treatment is provided
at a second visit, nearly fifty percent of women who test
positive for syphilis never receive treatment [7]. Point-of-
care diagnosis and same-day treatment are inexpensive, and
financial analyses in Haiti and elsewhere have demonstrated
their cost-effectiveness [8, 9]. Remarkably, same-day care has
been known for more than 25 years, yet reliable national
implementation of this practice remains elusive.
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Recognizing the cost-effectiveness of point-of-care diag-
nosis and same-day treatment of syphilis in pregnant women,
the Haitian Ministry of Health has established a national
goal of eliminating congenital syphilis by 2015 [2]. Here, we
report on the introduction of rapid test technology and health
systems improvement intervention at national scale in Haiti
to improve syphilis care and treatment for pregnant women.
Their sequential implementation allowed us to measure their
independent effects on syphilis case detection and treatment.
2. Methods
2.1. Ethics Statement. Approval for this study was obtained
from the ethics review boards of both the GHESKIO Centres
and Weill Cornell Medical College.
2.2. Study Sites. Fourteen geographically distributed clinics
throughout Haiti were selected for participation in this study.
We selected larger clinics that were supported by the US
Government’s PEFPAR program to provide PMTCT services
for pregnant women and that were supervised by staff from
theGHEKSIOCentres, aHaitian nongovernmental organiza-
tion based in Port-au-Prince. We describe the facility-based
characteristics of these sites including public versus private,
rural versus urban, and geographic location.
2.3. Study Design. Rapid syphilis testing technology and a
systems-based improvement intervention were introduced
sequentially to these fourteen PEPFAR-supported clinics over
51 months from 2007 to 2011. In the first phase of the
study, a syphilis point-of-care test (Standard Diagnostics
BIOLINE, Syphilis 3.0) was introduced to all clinical study
sites between January 2008 and April 2009. This was part
of a national program to incorporate point-of-care syphilis
testing at all PEPFAR sites in the country that were testing
pregnant women for HIV. In the second phase, a systems-
improvement intervention was introduced to all 14 study
sites simultaneously in October 2010. A time series analysis
was utilized to understand the effects of these interventions
occurring sequentially over the study period.
2.4. Interventions: Point of Care Tests with Traditional Edu-
cational Program. In 2008, the Haitian Ministry of Health
introduced routine prenatal syphilis screening using a rapid
syphilis test as part of a national plan to eliminate congenital
syphilis. Clinic staff attended a two-day lecture-based train-
ing on the epidemiology of syphilis, modes of transmission,
clinical manifestations, diagnosis, treatment, and prevention
of congenital syphilis. Laboratory technicians also attended
an additional one-day workshop to learn how to perform
the rapid point of care test. SD BIOLINE is a whole blood,
immunochromatographic assay for the qualitative detection
of antibodies of all isotypes against Treponema pallidum (SD
Bioline Syphilis 3.0, Kyonggi-Do, republic of Korea). No
additional equipment is required and all reagents can be
stored at room temperature. Test results were available within
30minutes at the point of care. Quality assurance of the rapid
test was done according to the manufacturer’s recommenda-
tions. Each rapid test includes a control test “band” to indicate
the appearance of a negative test. In addition, GHESKIO
runs known positive and known negative serums to assure
rapid test validity periodically. Studies from Haiti and other
countries show that the test is highly sensitive and specific
for the diagnosis of syphilis in pregnant women [10, 11]. In
our experience in Haiti, a positive rapid test is also positive
by RPR and confirmatory TPHA more than 95% of the time,
suggesting that the rapid test is diagnosing active infection in
more than 95% of cases.
2.5. Systems-Based Quality Improvement. Prior systems
strengthening efforts to improve coverage of syphilis care
and treatment have focused on laboratory support, supply
chain improvements, workforce training, and monitoring
and evaluation [12]. In 2010, GHESKIO used a systems-
based quality improvement (QI) approach to strengthen
prenatal syphilis screening and treatment. The effectiveness
of the QI approach to strengthen care delivery systems for
tuberculosis, HIV, maternal and child health, and PMTCT
has been documented in other resource-poor countries
[13–16]. The QI approach used a conceptual framework
called the “model for improvement” based on the original
work of statistician Deming [17, 18]. The approach uses local
facility-based systems improvement teams, composed of
facility staff, to select the best evidence-based healthcare
interventions, to conduct local gap and root-cause analyses
(fishbone Ishikawa diagrams) to diagnose systems failures,
and to use the plan-do-study-act (PDSA) rapid cycle change
approach to improve failing systems [17].
The QI approach addressed implementation failures at
each clinic using three techniques taught to clinic staff during
two workshops.
(1) Forming Multidisciplinary, Facility-Based Systems-
Improvement Teams. These teams, established at the
beginning of the intervention period, were composed
of the facility manager, at least one nurse, the data
clerk, and other interested facilitymembers. Each par-
ticipating site formed a systems-improvement team
and the size of these teams varied based on the size
of the clinic and availability of staff. All teams estab-
lished clear, facility-based improvement goals in each
clinical area, used root-cause analysis to understand
system barriers and process mapping to understand
patient flow and bottlenecks in clinical pathways.
They were asked to meet on a twice-monthly basis to
oversee the QI activities.
(2) Conducting Local Process Indicator Analysis. QI
experts from GHESKIO (2 of them) assisted the
facility-based teams to use their own local register
data to conduct facility-specific data analysis using
Pareto and basic run-chart analysis [19]. Such Pareto
and run-chart analyses allowed facility teams to visu-
ally depict service delivery gaps that were present in
their day-to-day work. This analysis was completed
on a monthly basis for all clinics.
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Table 1: Number and percent of pregnant women tested for syphilis.
Pregnant women Tested for syphilis Percent tested for syphilis
Prerapid test (24 months) 34776 31810 91.5
Postrapid test initiation (9 months) 16025 15373 95.9∗
Prequality improvement (9 months) 14137 13542 95.8
Postquality improvement initiation (9 months) 16435 15916 96.8∗
∗denotes significant increase compared to prerapid test rates with 𝑃 < 0.001.
(3) Using the Model for Improvement Systems Change
Strategy. Facility-based QI teams used a problem-
solving strategy based on the conceptual framework
offered by the model for improvement to implement
solutions to local barriers [17]. Job aids, distribution
of guidelines and new protocols, training materials,
changes to clinic flow, and other specific systems
improvement tools were employed to solve specific
systems failures or to reinforce the reliable perfor-
mance of a desired clinic behavior. The tool or tech-
nique which would be successful for each individual
clinic was not predicted at the outset. Each PDSA
cycle culminated in a decision about whether to
adopt, adapt, or abandon a specific systems change
based on whether it had produced an improved
service. Each clinic was encouraged to complete one
PDSA cycle each month during the intervention
period.
We documented the primary service delivery failures
and the corresponding specific solutions that were tested
and implemented by these facility-based teams. These data
were gathered during the two QI training sessions through
two techniques: focus group interviewing and presentations
by each facility involved with the initiative on key systems
barriers, solutions tested, and results obtained.
In all cases, partner notification was done by sending an
invitation card through the patient/pregnant woman. Data
on uptake of this intervention were not tracked as part of
this study; however, GHESKIO and its partners made every
effort to urge pregnant women to communicate their status to
their partners and would link them to testing and treatment
as soon as they presented for care.
2.6. Study Endpoints. The study focused on two clinical
measures: the proportion of all pregnant women tested for
syphilis and receiving their results, and the proportion of
those women testing positive who were subsequently treated
for syphilis during the antenatal period.
2.7. Data Collection and Analysis. Data were obtained from
the web-based MESI.HT health information system of the
Haitian Ministry of Health. Data were analyzed over a 51-
month time period, divided into four phases: prerapid test
(March 2007–March 2009), postrapid test initiation (April
2009–December 2009), prequality improvement (January
2010–September 2010), and postquality improvement initia-
tion (October 2010–June 2011).We also examined the effect of
the January 2010 earthquake on testing and treatment rates.
Logistic regression was used to compare testing and treat-
ment rates in all four study periods. Differences in the testing
and treatment rates between periods were further examined
using simultaneous tests for general linear hypotheses. 𝑃
values were controlled for multiple comparisons using the
Bonferroni method. Differences in clinic specific testing and
treatment rates in the four study periods were also examined
for all clinics in aggregate, for each individual clinic, and
for subgroups of clinics (public, private, urban and rural).
This analysis allowed us to see whether each intervention
was associated with a significant increase or decrease in
the outcome variables across all participating clinics in each
individual clinic and in each type of clinic. For clinics where
rates were close to 100%, Fisher’s exact test was used to
compare rates.
Using population estimates from the Ministry of Health,
rates of congenital syphilis, and the results of the logistic
regression, we estimated the effects of these interventions if
they were scaled up country wide. Our estimation is based
on a previously described model by Schackman et al. [9]
using the following assumptions: 320,000 pregnancies in
Haiti annually, a 4% syphilis positivity rate country wide,
and a 43.8% serious birth complication (stillbirth or neonatal
death) rate for untreatedmothers and a 1.1% complication rate
for treated mothers [3].
3. Results
Fourteen clinical sites participated in the study. Twelve sites
were characterized as hospitals (bed size ranged between
10 and 150) and two as clinics. The sites were evenly split
between publicly managed (𝑛 = 7) and privately operated by
nongovernmental organizations (NGOs). Eleven (78%) were
situated in urban settings and three (22%) were located in
rural settings. The average population in the catchment area
for the urban health facilities was 410,000 individuals (range
= 80,000–1.6 million). Average catchment areas for the rural
facilities was 55,000 (range = 32,000–79,000). All facilities
received the rapid syphilis test, and all facilities received the
two systems-based QI workshops. Under the systems-based
QI intervention, all facilities composed a multidisciplinary
team and all conducted at least one PDSA cycle during the
study period.
3.1. Syphilis Testing. During the baseline period, the overall
syphilis testing rate was 91.5% (Table 1). During the nine
months after the introduction of the rapid syphilis test,
the syphilis testing rate increased to 95.9% (𝑃 < 0.001).
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(b)
Figure 1: Change in syphilis treatment rate after the rapid syphilis test (a) and the introduction of quality improvement. (b) Each bar represents
one of the fourteen participating clinics and the direction represents the change in treatment rate compared with the preintervention period
(0.5 = 50%). the width of the bar represents the number of pregnant women that the clinic saw during the study period. The dotted line
represents the mean change across all sites.
Table 2: Number and percent of pregnant women treated for syphilis.
Syphilis positive pregnant women Treated for syphilis Percent treated for syphilis
Prerapid test (24 months) 1397 982 70.3
Postrapid test initiation (9 months) 652 487 74.7
Prequality improvement (9 months) 543 381 70.2
Postquality improvement initiation (9 months) 630 531 84.3∗
∗denotes significant increase compared to prerapid test rates with 𝑃 < 0.001.
After the January 2010 earthquake, the testing rate remained
similarly at 95.8%. After the QI intervention, further small
yet significant increase in testing rate to 96.8% was observed
(𝑃 < 0.001).
Despite the overall improvement in testing rates following
the interventions, substantial variation in subgroups of clinics
was observed. After the introduction of the rapid test, syphilis
testing rates in public clinics increased from 87.0% to 96.1%
(𝑃 < 0.001) whereas private clinics decreased from 98.1%
to 95.8% (𝑃 < 0.001). After the QI intervention, public
clinics improved significantly (93.2% to 95.5%, 𝑃 < 0.001)
while private clinics were not significantly different (99.4% to
99.2%).
3.2. Syphilis Treatment. During the baseline period, the
overall syphilis treatment rate was 70.3% (Table 2). During
the nine months after the introduction of the rapid syphilis
tests, the syphilis treatment rate increased to 74.7% which
was not statistically significant improvement compared to the
baseline after adjusting for multiple comparisons (𝑃 = 0.28).
After the 2010 earthquake, the treatment rate returned to
70.2%. Statistically significant improvement in treatment rate
was seen after QI to 84.3% compared to each of the previous
study periods (𝑃 < 0.001) Figure 1.
After the rapid test was introduced, treatment rates
improved in public clinics (64.4% to 75.3%, 𝑃 = 0.002) but
not in private clinics. After the QI intervention, all clinics had
improved treatment rates with the greatest gains in private
clinics (private: 68.5% to 93.6%, 𝑃 < 0.001; public: 71.6% to
78.1%, 𝑃 = 0.36).
3.3. Systems Barriers to Same-Day Testing and Treat-
ment. During the quality improvement intervention, clinics
described their key systembarriers and the solutions that they
used to overcome them. A summary of the systems barriers
and solutions is detailed in Table 3.
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Table 3: Health system areas addressed by the intervention, problems, and solutions.
(1) Stock management of syphilis tests and penicillin
Problems Solutions
(i) Frequent outages of lab tests and penicillin
(ii) No communication within health facility between clinic staff
using tests/drugs and stock room/pharmacy
(iii) Multiple approvals and administrative layers for facility to
reorder rapid syphilis tests and penicillin from national supplier
(iv) Requisitions from facility to national supplier often late
(v) National supplier often has stock outages of penicillin
(i) Clinic inventory and communication between clinic staff and
pharmacy
(ii) Earlier requisition by facility of larger stocks from national
supplier
(iii) Creation of a reserve stock of penicillin
(iv) Emergency budget for local procurement of penicillin
(v) National supplier of medications includes penicillin as essential
drug
(2) Task shifting among health facility staff as syphilis testing moves from laboratory to the point-of-care
Problems Solutions
(i) Clinical staff reports insufficient time to perform rapid syphilis
tests on every pregnant woman
(ii) Laboratory staff reluctant to give up work and fear job loss
(iii) Injectable benzathine penicillin located in pharmacy and
given by pharmacists only and not in clinic
(iv) Job descriptions do not match new responsibilities
(i) Staff becomes more “polyvalent” and performs multiple tasks
(ii) Staff backs each other up in case one becomes busy
(iii) Laboratory staff comes to clinic to draw blood and perform
test on site
(iv) HIV counselors taught to draw blood
(v) Retraining and continuing education
(vi) Team building with goal of preventing newborn death
(3) Patient flow through the health facility
Problems Solutions
(i) Multistep process between pregnant woman’s arrival to clinic,
testing for syphilis, and penicillin injection. “The clinic process
resembles an obstacle course for pregnant woman”
(ii) Bottlenecks (waiting for clinic chart; waiting for test results;
etc.)
(iii) Long lines and waits between each step
(iv) Frustrated pregnant women leave clinic between steps
(i) Simplify flow and decrease number of steps
(ii) Give priority to pregnant women at key points of care
(phlebotomy, pharmacy)
(iii) “Mobile laboratory staff” within facility to perform lab test in
clinic rooms
(iv) Group counseling, education, and phlebotomy of all pregnant
women in clinic waiting areas
(v) Decentralize prenatal care and syphilis screening to satellite
facilities to decrease patient volume at large clinics
(4) Data collection and evaluation
Problems Solutions
(i) Clinic data flows up to administration, ministry, and PEPFAR
but is not available in real time for clinic staff
(ii) No locally available indicators on percent of pregnant women
tested for syphilis and percent of syphilis positive women treated
(iii) Need immediate feedback to reward and motivate staff
(iv) Need to correct problems in real time and not wait for a report
from a central authority
(i) Use local registers to track a few key indicators
(ii) Local “improvement teams” meet regularly to review and
report indicators to all staff
(iii) Data entry programs redesigned to generate local reports in
real time
(5) Patient and community participation
Problems Solutions
(i) Women do not know about the dangers of congenital syphilis
and importance of screening during pregnancy
(ii) Women afraid of injection needle and refuse penicillin
(iii) Community needs to hold health facility accountable for
syphilis screening
(i) “Bottom up accountability,” by informing women in the
community about dangers of congenital syphilis and that they
have a right to free prenatal syphilis screening
(ii) Community health workers encourage pregnant women to
seek prenatal care and screening
(iii) Include community members in discussions of how best to
provide prenatal care and syphilis screening
3.4. Adverse Events Averted. Given the geographic spread of
this project and the size of the involved clinics, we estimated
that if the two interventions were scaled up country wide,
this would result in 16,612 additional pregnant women being
screened for syphilis, an additional 2,008 pregnant women
treated for syphilis, and 567 fewer babies stillborn or born
with serious complications of congenital syphilis every year.
4. Discussion
Both technology- and health systems-based interventions
improve the delivery of prenatal services to prevent con-
genital syphilis in Haiti. Technology-based solutions in the
absence of systems-improvement interventions will have
minimal impact on clinical outcomes. In the case of syphilis
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in Haiti, the availability of a rapid test improved diagnostic
testing rates, but it did not significantly affect rates of
treatment. The Haitian earthquake in January 2010 did not
have significant effects on syphilis testing rates but did cause
small but significant declines in syphilis treatment which
were overcome during the QI intervention.
Rapid syphilis testing and treatment required a combina-
tion of point-of-care testing and systems-based interventions
to improve the clinic organization, human resources, supply
chain, and other management structures to ensure concur-
rent improvements to treatment delivery. In a randomized
trial from SouthAfrica, point-of-care syphilis testing reduced
testing delays; however, there was no significant difference in
overall treatment rates [20]. Similar results were found with a
point-of-care CD4 test where rapid results had limited impact
on HIV treatment initiation [21].
Our results should inform global efforts to eliminate con-
genital syphilis [22]. Some 10% of women in resource-limited
settings are infected with syphilis and over 490,000 babies are
born annually with syphilis in Sub-SaharanAfrica [23, 24]. In
some countries, syphilis is the largest cause of stillbirths and
an important cause of premature infant death [25]. Despite
availability of rapid tests, prenatal syphilis treatment rates
remain below 40% [26]. Our data suggest combining rapid
test technology and health systems improvement could lead
to large scale implementation success.
Our result are consistent with a growing body of evidence
suggesting that quality improvement systems strengthening
interventions can successfully increase access to HIV, tuber-
culosis, and maternal and child health care in resource-
limited settings [14, 27–30]. We are now using the QI
approach to strengthen HIV and TB integration in Haiti.
These results suggest an important lesson for those
introducing new health care technologies in resource-limited
settings. When new technologies are introduced, the health
system must be adjusted to take advantage of what the
new technology offers. This adjustment does not happen
automatically without deliberating attention to health system
change. In fact, as new therapeutic, diagnostic and preven-
tative technologies are introduced, the gap between what is
possible and the actual performance of health systems may
grow wider. This “technology to systems gap” means that
clinically important discoveries are often held hostage to the
inability of our health systems to deliver them. We need
parallel investments in systems transformation to ensure that
all patients can reap the benefits of clinically meaningful new
technologies.
Our data suggest that the introduction of the rapid
test technology had its biggest impact in public clinics.
We postulate that breakdowns in lab equipment prior to
the intervention made rapid-test technology (which require
minimal equipment) very advantageous. All clinics, both
public and private, benefitted from the quality improvement
intervention.
The main strengths of our study were the large sample
size and geographic spread across fourteen large clinics in
a number of heterogeneous settings. The main limitation of
this study is the lack of matched concurrent control facilities.
As the study took place within PEPFAR’s programmatic
constraints, we were not afforded a matched control group.
In addition, the high baseline testing rates at all time points
did not allow marked improvements in testing rates. While
this is certainly a limitation, this does not obscure the impact
of the systems improvement intervention on treatment rates.
Our results, despite being encouraging, require further
validation in additional implementation research environ-
ments, continued study to evaluate sustainability, and costing
studies to establish cost-effectiveness of the combined tech-
nology and systems-based interventions. Our experience in
Haiti demonstrates that health systems improvement efforts
coupled with technology can improve care delivery systems
to prevent congenital syphilis in resource-poor settings.
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